Purchase Order 75N91025P00202

Award Date 2/11/25
Potential Completion Date 2/10/26
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $18,450 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. The contract is for a service agreement with a completion date of January 9, 2026. Miltenyi Biotec, which is a foreign-owned, for-profit manufacturer, has extensive experience as a prime...
This is a firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency, to Miltenyi Biotec, Inc. for a maintenance agreement. The contract has a ceiling value of $91,800.00 and a period of performance ending on August 10, 2024. The contract does not have a set-aside designation. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The contract, valued at $13,995.00, is for other functions maintenance agreement services. Miltenyi Biotec provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation....
This is a $24,999.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of specialized laboratory equipment and reagents. The contract is for the delivery of unspecified laboratory equipment, with a period of performance through September 7, 2024. While not awarded under a set-aside program, Miltenyi Biotec has extensive...
This is a $26,525 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services. The award is for "MACSQUANT TYTO ESSENTIAL SERVICE" with an ultimate completion date of November 4, 2025. Miltenyi Biotec has extensive experience as a prime contractor for numerous federal agencies, including the NIH, VA, FDA, DoD,...
This is a $19,325.00 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is for the provision of specialized scientific equipment and associated maintenance services,...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The $5,550 contract is for the maintenance plan and service agreement for an AutoMACS Pro Separator, a specialized cell separation instrument. Miltenyi Biotec is a prime contractor with extensive experience providing a range of cell processing equipment, reagents, and...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company, for preventative maintenance services on the CliniMACS Prodigy cell processing system. The contract has a ceiling value of $71,087 and a period of performance through August 31, 2026. Miltenyi Biotec, a foreign-owned for-profit manufacturer, is the prime contractor and there is no set-aside designation. The award is part of a...
This is a $4,250 firm-fixed-price purchase order contract between the National Institute of Allergy and Infectious Diseases (NIAID) and Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services. The contract is not set aside and supports NIAID's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Miltenyi Biotec has extensive experience as a prime contractor for numerous...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company, for one-time planned maintenance on an AUTOMACS Pro cell separator. The $4,194 contract has a completion date of March 31, 2018 and was awarded on January 29, 2018 without any set-aside designation. Miltenyi Biotec is an experienced federal contractor, providing...

This is a $19,325 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI) to Miltenyi Biotec, Inc. on February 11, 2025. The contract is for a maintenance agreement with a performance period through February 10, 2026. This award does not have a set-aside designation.

Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. The company frequently serves as a prime contractor for federal agencies, delivering a range of products and services related to cell separation, analysis, and processing technologies. This contract likely involves the maintenance and servicing of Miltenyi Biotec's instruments and equipment installed at NCI facilities. The company holds a significant single-award indefinite delivery contract (IDC) with the NIH Clinical Center to supply proprietary CliniMACS cell isolation reagents and consumables in support of cell therapy manufacturing for NIH clinical trials.

Generated 2/12/25, 9:20 AM